These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2032792)

  • 21. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoporosis: monitoring techniques and alternate therapies. Calcitonin, fluoride, bisphosphonates, vitamin D.
    Baran DT
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):321-35. PubMed ID: 7936547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of established osteoporosis].
    Lamy O; Burckhardt P; Thiébaud D
    Rev Med Suisse Romande; 1995 Feb; 115(2):121-6. PubMed ID: 7886366
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhibition of progression of decreasing bone mass and manifest osteoporosis].
    Ringe JD
    Internist (Berl); 1993 Apr; 34(4):300-6. PubMed ID: 8486473
    [No Abstract]   [Full Text] [Related]  

  • 25. [The new concept of osteoporosis. Early diagnosis, prevention and therapy are possible today].
    Hesch RD; Harms H; Rittinghaus EF; Brabant G
    Fortschr Med; 1990 Apr; 108(11):219-21. PubMed ID: 2358288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current treatment concepts in primary osteoporosis: calcitonin].
    Ringe JD
    Schweiz Med Wochenschr; 1993 Nov; 123(47):2235-40. PubMed ID: 8272794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitonins and osteoporosis.
    Gennari C; Agnusdei D
    Br J Clin Pract; 1994; 48(4):196-200. PubMed ID: 7917799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of fluorides in the treatment of postmenopausal osteoporosis].
    Mosekilde L
    Ugeskr Laeger; 2001 Aug; 163(32):4172-4. PubMed ID: 11510231
    [No Abstract]   [Full Text] [Related]  

  • 29. [Early therapy of osteoporosis with (1-38) parathyroid hormone and calcitonin nasal spray].
    Hesch RD; Rittinghaus EF; Harms HM; Delling G
    Med Klin (Munich); 1989 Oct; 84(10):488-98. PubMed ID: 2685534
    [No Abstract]   [Full Text] [Related]  

  • 30. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optimal osteoporosis strategy?].
    Scharla S; Reichenhall B
    Krankenpfl J; 2005; 43(1-3):65. PubMed ID: 15912853
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of special studies with alendronate.
    McClung M
    Int J Clin Pract Suppl; 1999 Apr; 101():67-72. PubMed ID: 12669743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium and vitamin D in the prevention and treatment of osteoporosis.
    Orcel P
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):70S-74S. PubMed ID: 9273942
    [No Abstract]   [Full Text] [Related]  

  • 35. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].
    Vogel M; Hesch RD; Delling G
    Med Klin (Munich); 1990 Feb; 85(2):82-6. PubMed ID: 2319988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Using miacalcic nasal spray 200 UI in the treatment of osteoporosis in women of 40-70 years of age during menopause according to data of the center "Osteoporosis" in Khaskovo city].
    Staĭkova N; Filipov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():10-4. PubMed ID: 15323311
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral calcitonin.
    Maricic MJ
    Curr Osteoporos Rep; 2012 Mar; 10(1):80-5. PubMed ID: 22281725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intra-nasal calcitonin for the prevention of postmenopausal osteoporosis].
    Meunier PJ
    Rev Med Univ Navarra; 1992; 37(4):200-4. PubMed ID: 1298037
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcitonin in the treatment of osteoporosis.
    Gennari C; Camporeale A
    Osteoporos Int; 1997; 7 Suppl 3():S159-62. PubMed ID: 9536324
    [No Abstract]   [Full Text] [Related]  

  • 40. [The efficacy of osteoquin in treating the postmenopausal and senile forms of osteoporosis].
    Rodionova SS
    Ter Arkh; 1995; 67(10):43-5. PubMed ID: 8779104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.